These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 3943086

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of 5-diazouracil on the catabolism of circulating pyrimidines in rat liver and kidneys.
    Holstege A, Pausch J, Gerok W.
    Cancer Res; 1986 Nov; 46(11):5576-81. PubMed ID: 3756903
    [Abstract] [Full Text] [Related]

  • 7. Nonlinear pharmacokinetics of thymidine, thymine, and fluorouracil and their kinetic interactions in normal dogs.
    Covey JM, Straw JA.
    Cancer Res; 1983 Oct; 43(10):4587-95. PubMed ID: 6883317
    [Abstract] [Full Text] [Related]

  • 8. 5-Ethynyluracil (776C85): effects on the antitumor activity and pharmacokinetics of tegafur, a prodrug of 5-fluorouracil.
    Cao S, Baccanari DP, Joyner SS, Davis ST, Rustum YM, Spector T.
    Cancer Res; 1995 Dec 15; 55(24):6227-30. PubMed ID: 8521418
    [Abstract] [Full Text] [Related]

  • 9. In vivo potentiation of 5-fluorouracil cytotoxicity against AKR leukemia by purines, pyrimidines, and their nucleosides and deoxynucleosides.
    Santelli G, Valeriote F.
    J Natl Cancer Inst; 1980 Jan 15; 64(1):69-72. PubMed ID: 6928048
    [Abstract] [Full Text] [Related]

  • 10. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON, Rais R, Shi J, Schinazi RF, Naguib FN, el Kouni MH.
    Cancer Chemother Pharmacol; 2006 Nov 15; 58(5):692-8. PubMed ID: 16528530
    [Abstract] [Full Text] [Related]

  • 11. In vivo effect of 5-ethynyluracil on 5-fluorouracil metabolism determined by 19F nuclear magnetic resonance spectroscopy.
    Adams ER, Leffert JJ, Craig DJ, Spector T, Pizzorno G.
    Cancer Res; 1999 Jan 01; 59(1):122-7. PubMed ID: 9892196
    [Abstract] [Full Text] [Related]

  • 12. Lethal drug interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs.
    Okuda H, Nishiyama T, Ogura K, Nagayama S, Ikeda K, Yamaguchi S, Nakamura Y, Kawaguchi K, Watabe T, Ogura Y.
    Drug Metab Dispos; 1997 Feb 01; 25(2):270-3. PubMed ID: 9029059
    [Abstract] [Full Text] [Related]

  • 13. Intratumoral injection of thymidine: enhancement of the antitumor activity and incorporation of 5-fluorouracil into tumor RNA in a murine tumor system.
    Matsuoka H, Masuda H, Maehara Y, Sugimachi K, Inokuchi K.
    Cancer Treat Rep; 1986 Jul 01; 70(7):851-7. PubMed ID: 3719577
    [Abstract] [Full Text] [Related]

  • 14. Prediction of in vivo drug-drug interactions based on mechanism-based inhibition from in vitro data: inhibition of 5-fluorouracil metabolism by (E)-5-(2-Bromovinyl)uracil.
    Kanamitsu SI, Ito K, Okuda H, Ogura K, Watabe T, Muro K, Sugiyama Y.
    Drug Metab Dispos; 2000 Apr 01; 28(4):467-74. PubMed ID: 10725316
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts.
    Tatsumi K, Fukushima M, Shirasaka T, Fujii S.
    Jpn J Cancer Res; 1987 Jul 01; 78(7):748-55. PubMed ID: 3114201
    [Abstract] [Full Text] [Related]

  • 16. Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate.
    Ho DH, Townsend L, Luna MA, Bodey GP.
    Anticancer Res; 1986 Jul 01; 6(4):781-4. PubMed ID: 3752956
    [Abstract] [Full Text] [Related]

  • 17. A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs.
    Okuda H, Ogura K, Kato A, Takubo H, Watabe T.
    J Pharmacol Exp Ther; 1998 Nov 01; 287(2):791-9. PubMed ID: 9808711
    [Abstract] [Full Text] [Related]

  • 18. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D.
    Toxic Rep Ser; 1995 Apr 01; 30():1-G5. PubMed ID: 12209194
    [Abstract] [Full Text] [Related]

  • 19. 5-Fluorouracil prodrug: role of anabolic and catabolic pathway modulation in therapy of colorectal cancer.
    Cao S, Frank C, Shirasaka T, Rustum YM.
    Clin Cancer Res; 1995 Aug 01; 1(8):839-45. PubMed ID: 9816053
    [Abstract] [Full Text] [Related]

  • 20. In vivo antitumor activity of the bitter melon (Momordica charantia).
    Jilka C, Strifler B, Fortner GW, Hays EF, Takemoto DJ.
    Cancer Res; 1983 Nov 01; 43(11):5151-5. PubMed ID: 6616452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.